Cargando…

Anti-angiogenic agents in the treatment of non-small cell lung cancer

Lung cancer is the most common malignant neoplasm diagnosed worldwide. In Poland, in 2011, lung cancer was diagnosed in 14,522 men and 6,283 women. Morbidity and mortality are nearly equal, and lung cancer is still the most common cause of cancer-related death among men as well as among women. Appro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szyszka-Barth, Katarzyna, Ramlau, Katarzyna, Stencel, Dariusz, Ramlau, Rodryg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2014
Materias:	Thoracic Surgery
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283868/ https://www.ncbi.nlm.nih.gov/pubmed/26336412 http://dx.doi.org/10.5114/kitp.2014.43841

Ejemplares similares

Treatment of Brain Metastases of Non-Small Cell Lung Carcinoma
por: Rybarczyk-Kasiuchnicz, Agnieszka, et al.
Publicado: (2021)

Non-Small-Cell Lung Cancer: New Rare Targets—New Targeted Therapies—State of The Art and Future Directions
por: Stencel, Katarzyna, et al.
Publicado: (2021)

Neoadjuvant and Adjuvant Immunotherapy in Non-Small Cell Lung Cancer—Clinical Trials Experience
por: Chmielewska, Izabela, et al.
Publicado: (2021)

Actual status of therapeutic vaccination in non-small cell lung cancer
por: Szyszka-Barth, Katarzyna, et al.
Publicado: (2014)

Erlotinib in salvage treatment of patients with advanced non-small cell lung cancer: results of an expanded access programme in Poland
por: Kowalski, Dariusz M., et al.
Publicado: (2012)

Percentages of NKT cells in the tissues of patients with non-small cell lung cancer who underwent surgical treatment
por: Pyszniak, Maria, et al.
Publicado: (2014)

Current views on molecularly targeted therapy for lung cancer – a review of literature from the last five years
por: Rybarczyk-Kasiuchnicz, Agnieszka, et al.
Publicado: (2018)

Completion pneumonectomy and chemoradiotherapy as treatment options in local recurrence of non-small-cell lung cancer
por: Kasprzyk, Mariusz, et al.
Publicado: (2015)

Combining radiotherapy with targeted therapies in non-small cell lung cancer: focus on anti-EGFR, anti-ALK and anti-angiogenic agents
por: Wrona, Anna, et al.
Publicado: (2021)

Neoadjuvant chemotherapy is a risk factor for bronchopleural fistula after pneumonectomy for non-small cell lung cancer
por: Samancilar, Ozgur, et al.
Publicado: (2014)

Pre-COVID-19 National Mortality Trends in Open and Video-Assisted Lobectomy for Non-Small Cell Lung Cancer
por: Dezube, Aaron R., et al.
Publicado: (2022)

Phase II study of two dose schedules of C.E.R.A. (Continuous Erythropoietin Receptor Activator) in anemic patients with advanced non-small cell lung cancer (NSCLC) receiving chemotherapy
por: Hirsh, Vera, et al.
Publicado: (2007)

Modeling the COVID Pandemic: Do Delays in Surgery Justify Using Stereotactic Radiation to Treat Low-Risk Early Stage Non–Small Cell Lung Cancer?
por: Cao, Lifen, et al.
Publicado: (2023)

Surgical treatment of tumours of the sternum – 10 years’ experience
por: Kozak, Katarzyna, et al.
Publicado: (2016)

The rationale for HPV-related oropharyngeal cancer de-escalation treatment strategies
por: Wierzbicka, Małgorzata, et al.
Publicado: (2015)

Results of surgical treatment of primary lung cancer with synchronous brain metastases
por: Bella, Mariusz Jan, et al.
Publicado: (2015)

Intramural esophageal tumors
por: Łochowski, Mariusz P., et al.
Publicado: (2016)

Loss of STING expression is prognostic in non–small cell lung cancer
por: Lohinai, Zoltan, et al.
Publicado: (2022)

Midterm survival of imaging-assisted robotic lung segmentectomy for non-small-cell lung cancer
por: Chaari, Zied, et al.
Publicado: (2021)

Segmentectomy versus lobectomy for inner-located small-sized early non-small-cell lung cancer
por: Tane, Shinya, et al.
Publicado: (2022)

Lung cancer resection in patients with underlying usual interstitial pneumonia: a meta-analysis
por: Patel, Akshay Jatin, et al.
Publicado: (2023)

Textbook outcome as a composite outcome measure in non-small-cell lung cancer surgery
por: ten Berge, Martijn G, et al.
Publicado: (2020)

Videothoracoscopic Bronchial Sleeve Resection for Non-Small Cell Lung Cancer
por: Celik, Ali, et al.
Publicado: (2021)

Feasibility of double sleeve lobectomy after neoadjuvant chemotherapy in patients with non-small-cell lung cancer
por: Bao, Yi, et al.
Publicado: (2022)

Importance of tumour volume and histology in trimodality treatment of patients with Stage IIIA non-small cell lung cancer—results from a retrospective analysis
por: Joosten, Pieter J M, et al.
Publicado: (2021)

Is video-assisted thoracoscopic surgery comparable with thoracotomy in perioperative and long-term survival outcomes for non-small-cell lung cancer after neoadjuvant treatment?
por: Wang, Yi-Feng, et al.
Publicado: (2022)

Serial characterisation of monocyte and neutrophil function after lung resection
por: Jones, Richard O, et al.
Publicado: (2014)

The Markers of Glutamate Metabolism in Peripheral Blood Mononuclear Cells and Neurological Complications in Lung Cancer Patients
por: Michalak, Slawomir, et al.
Publicado: (2016)

The analysis of ALK gene rearrangement by fluorescence in situ hybridization in non-small cell lung cancer patients
por: Wojas-Krawczyk, Kamila, et al.
Publicado: (2013)

Postoperative cerebral infarction risk is related to lobectomy site in lung cancer: a retrospective cohort study of nationwide data in Japan
por: Nishizawa, Natsumasa, et al.
Publicado: (2022)

Segmentectomy versus wedge resection for radiological solid predominant and low metabolic non-small cell lung cancer
por: Kagimoto, Atsushi, et al.
Publicado: (2022)

Implementation of a Novel, Single-Encounter Telemedicine Lung Cancer Screening During COVID-19 Preserves Access among African Americans
por: Magarinos, Jessica S., et al.
Publicado: (2021)

Exercise oxygen desaturation is a predictor of cardiopulmonary complications after lung resection
por: Fukui, Mariko, et al.
Publicado: (2022)

The COVID-19 Era Is Associated With Delays in Esophageal Cancer Diagnosis and Treatment
por: Khan, Hamza, et al.
Publicado: (2023)

Correlation between KRAS, NRAS and BRAF mutations and tumor localizations in patients with primary and metastatic colorectal cancer
por: Bożyk, Aleksandra, et al.
Publicado: (2021)

Epidermal growth factor receptor (EGFR)—tyrosine kinase inhibitors as a first-line treatment for postoperative recurrent and EGFR-mutated non-small-cell lung cancer
por: Moriya, Tetsuji, et al.
Publicado: (2021)

Pretreatment prediction of tumour spread through air spaces in clinical stage I non-small-cell lung cancer
por: Ding, Yun, et al.
Publicado: (2022)

Is it possible to standardize the treatment of primary spontaneous pneumothorax? Part 2: surgical methods of treatment
por: Rokicki, Wojciech, et al.
Publicado: (2016)

Neoadjuvant Therapy and Factors Influencing Survival in Locally Advanced Non-Small Cell Lung Cancer
por: Ebinç, Senar, et al.
Publicado: (2023)

A population-based study of hospital length of stay and emergency readmission following surgery for non-small-cell lung cancer
por: McDevitt, Joseph, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_gu5j50vk4d4ud6v44v5n3usjim